Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Saint-Luc University Hospital, Brussels

Universitair Ziekenhuis Antwerpen, Edegem

Herlev and Gentofte Hospital, Herlev

Universitair Ziekenhuis Leuven, Leuven

CHU de Liège, Liège

CHU UCL Namur - Sainte Elisabeth, Namur

CHU UCL Namur - site Godinne, Yvoir

Grand Hôpital de Charleroi, Charleroi

Centre Hospitalier Universitaire Ambroise Paré, Mons

Karolinska Universitetssjukhuset, Stockholm

University of Virginia, Charlottesville

University Gynecologic Oncology, Atlanta

University of Miami, Miami

Sarah Cannon Research Institute, Nashville

Lungemedicinska Kliniken, Linköping

MD Anderson Cancer Center, Houston

Comprehensive Cancer Centers of Nevada, Las Vegas

University of California Irvine Medical Center (UCIMC), Orange

Yale Cancer Center, New Haven

Rigshospitalet, Copenhagen University Hospital, Copenhagen

The Leeds Teaching Hospitals NHS Trust, Leeds

University College London Hospitals, London

Sarah Cannon Research Institute - London, London

Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne

The Royal Marsden NHS Foundation Trust, Sutton

Velindre NHS Trust, Cardiff

Beatson Cancer Centre, Glasgow

Guys hospital, London

The Christie NHS Foundation Trust, Manchester